KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Current Deferred Revenue (2017 - 2026)

Elanco Animal Health's Current Deferred Revenue history spans 9 years, with the latest figure at $416.0 million for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue rose 25.3% to $416.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $416.0 million, a 25.3% increase, with the full-year FY2025 number at $416.0 million, up 25.3% from a year prior.
  • Current Deferred Revenue hit $416.0 million in Q4 2025 for Elanco Animal Health, up from $376.0 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for ELAN hit a ceiling of $416.0 million in Q4 2025 and a floor of $284.0 million in Q2 2022.
  • Historically, Current Deferred Revenue has averaged $334.0 million across 5 years, with a median of $330.0 million in 2021.
  • Biggest five-year swings in Current Deferred Revenue: skyrocketed 84.76% in 2021 and later dropped 10.27% in 2022.
  • Tracing ELAN's Current Deferred Revenue over 5 years: stood at $319.0 million in 2021, then increased by 1.57% to $324.0 million in 2022, then grew by 13.27% to $367.0 million in 2023, then decreased by 9.54% to $332.0 million in 2024, then grew by 25.3% to $416.0 million in 2025.
  • Business Quant data shows Current Deferred Revenue for ELAN at $416.0 million in Q4 2025, $376.0 million in Q3 2025, and $367.0 million in Q2 2025.